Sun Pharmaceutical
SUNPHARMA · NSE · Pharma · India
Revenue (FY2026)
₹58,462 Cr
Net margin
19.6%
New to these? P/E, ROE, ROCE and more in Learn.
Ask MarketChacha about SUNPHARMA
Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.
Financials
Revenue trend
Yearly
| Period | Revenue | Net profit | Net margin |
|---|---|---|---|
| FY2026 | ₹58,462 Cr | ₹11,479 Cr | 19.6% |
| FY2025 | ₹52,578 Cr | ₹10,929 Cr | 20.8% |
| FY2024 | ₹48,497 Cr | ₹9,576 Cr | 19.7% |
| FY2023 | ₹43,886 Cr | ₹8,474 Cr | 19.3% |
Quarterly
| Period | Revenue | Net profit | Net margin |
|---|---|---|---|
| 2026Q1 | ₹14,612 Cr | ₹2,714 Cr | 18.6% |
| 2025Q4 | ₹15,521 Cr | ₹3,369 Cr | 21.7% |
| 2025Q3 | ₹14,478 Cr | ₹3,118 Cr | 21.5% |
| 2025Q2 | ₹13,851 Cr | ₹2,279 Cr | 16.5% |
Figures as reported, in ₹ (crore). Source: Yahoo Finance.
Filings & announcements
2026
Business Responsibility and Sustainability Report for FY 26
BSE7/16/2026Notice of 21st Annual General Meeting along with the Annual Report for FY 26
BSE7/16/2026materialSun Pharma Advanced Research Company Ltd - 532872 - Reg. 34 (1) Annual Report.
Annual Report 2025-26 and the Notice of 21st Annual General Meeting
BSE7/16/2026Press Release
BSE7/15/2026Notice of 34th Annual General Meeting along with the Annual Report for FY 2025-26
BSE7/6/2026materialAnnual Report 2025-26 and the Notice of 34th Annual General Meeting
BSE7/6/202621st Annual General Meeting of the Company
BSE7/6/2026materialIntimation regarding Change in Senior Management Team of the Company
BSE6/26/2026Termination of License Agreement with CMS Bridging DMCC
BSE6/25/2026Acquisition of Innovcare Lifesciences Private Limited
BSE6/20/2026material- BSE6/14/2026
In the news
- Sun Pharma among 5 stocks that hit 52-week highs & rallied up to 20% in a monthThe Economic Times · 7/16/2026
- Nifty Pharma hits record high; Divi's Labs, Torrent Pharma, Sun Pharma shares shineBusiness Today · 7/15/2026
- Sun Pharma Hits 52-Week High After South Africa Approves GLP-1 Drug SemaglutideNDTV Profit · 7/15/2026
- Sun Pharma gets nod for Semaglutide injection in South AfricaBusiness Standard · 7/15/2026
- Sun Pharma to manufacture and market Semaglutide in South Africa; shares trade in greenUpstox · 7/15/2026
- Sun Pharma To Launch Generic Semaglutide For Type 2 Diabetes In South AfricaNDTV Profit · 7/15/2026
- Trade Spotlight: How should you trade Sun Pharma, Balrampur Chini Mills, Blue Star, Caplin Point Labs,...Moneycontrol.com · 7/15/2026
- Stock Alert: ICICI Prudential Asset Management, HCL Tech, PDS, Sun Pharma Advanced ResearchBusiness Standard · 7/14/2026
Education and discussion only — not investment advice. Data from official filings (SEC/BSE), reported company financials, and news — not live exchange quotes. Verify with the linked sources before acting.